Drug Index

Tranexamic acid

 
print

Mechanism :

Tranexamic acid is a competitive inhibitor of plasminogen activation, and at much higher concentrations, a noncompetitive inhibitor of plasmin, i.e., actions similar to aminocaproic acid. Tranexamic acid is about 10 times more potent in vitro than aminocaproic acid.


Indication :

• Hereditary angioedema

• Menorrhagia

• Thrombolytic overdose

• Epistaxis palliation

• Mucus membrane bleeds

• Hyphema


Contraindications :

Contraindicated in patients with acquired defective color vision, in patients with subarachnoid hemorrhage, in patients with active intravascular clotting, in massive hematuria.


Dosing :

Oral

Menorrhagia:

1300 mg thrice daily, oral, for upto 5 days during menstruation.

Hereditary angioedema:

Short term prophylaxis: 75 mg/kg/day PO in 2-3 divided doses for 5 days before and after event.

Long term prophylaxis: 1000-1500 mg PO in 2-3 divided doses.

Treatment of acute attack: 25 mg/kg/dose IV/oral, max 1000 mg/dose every 3-4 hours.

Cone biopsy:

1000-1500 mg PO every 8-12 hours for 12 days postoperatively.

Epistaxis, Hyphema:

1000-1500 mg PO every 8-12 hours for 7-10 days.


Adverse Effect :

Nausea and vomiting, diarrhea, back pain, abdominal pain, nasal and sinus symptoms, headache, disturbances in color vision. Rapid IV injection may cause dizziness with or without the occurrence of hypotension.


Interaction :

Drug Interactions Not Available.


07/15/2019 05:42:52 Tranexamic acid
ask a doctor
Ask a Doctor
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0